Rafael Coveñas Ph.D
University of Salamanca, Spain · Spain
Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601
Research interests
- Neuropeptides
- Diencephalon
- Immunocytochemistry
- Multiple Sclerosis
- Nk-1 Receptor
- Cancer
Biography
Dr. Rafael Coveñas is affiliated with the University of Salamanca, Spain, where his research focuses on neuropeptides, diencephalon anatomy, immunocytochemistry, multiple sclerosis, and the NK-1 receptor. His work has contributed significantly to understanding neuropeptide systems and their therapeutic implications. His most-cited publication, "The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?" (2020), has received 92 citations and exemplifies his interest in translating neurokinin receptor research to clinical applications. Dr. Coveñas has authored over 43 indexed publications in the field of neuroscience.
Selected publications
- The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer? 2020 cited 92×
- Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies 2023 cited 38×
- The Galaninergic System: A Target for Cancer Treatment 2022 cited 36×
- Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides 2021 cited 35×
- Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer 2022 cited 30×
- The Neurokinin‐1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma 2022 cited 27×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JHOR for your work?
This journal is guided by Rafael Coveñas (University of Salamanca, Spain) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.